|
|
Tanaffos، جلد ۱۸، شماره ۳، صفحات ۱۸۰-۲۰۷
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Pulmonary Hypertension in Intensive Care Units: An Updated Review |
|
| چکیده انگلیسی مقاله |
Pulmonary hypertension (PH) is a condition associated with high morbidity and mortality. Patients with PH who require critical care usually have severe right ventricular (RV) dysfunction. Although different groups of PH have different etiologies, pulmonary vascular dysfunction is common in these groups. PH can lead to increased pulmonary artery pressure, which can ultimately cause RV failure. Clinicians should be familiar with the presentations of this disease and diagnostic tools. The contributing factors, if present (e.g., sepsis), and coexisting conditions (e.g., arrhythmias) should be identified and addressed accordingly. The preload should be optimized by fluid administration, diuretics, and dialysis, if necessary. On the other hand, the RV afterload should be reduced to improve the RV function with pulmonary vasodilators, such as prostacyclins, inhaled nitric oxide, and phosphodiesterase type 5 inhibitors, especially in group 1 PH. Inotropes are also used to improve RV contractility, and if inadequate, use of ventricular assist devices and extracorporeal life support should be considered in suitable candidates. Moreover, vasopressors should be used to maintain systemic blood pressure, albeit cautiously, as they increase the RV afterload. Measures should be also taken to ensure adequate oxygenation. However, mechanical ventilation is avoided in RV failure. In this study, we reviewed the pathophysiology, manifestations, diagnosis, monitoring, and management strategies of PH, especially in intensive care units. |
|
| کلیدواژه‌های انگلیسی مقاله |
Pulmonary hypertension,Pulmonary arterial hypertension,Intensive care,Critical care |
|
| نویسندگان مقاله |
Armin Nowroozpoor |
Clinical Tuberculosis and Epidemiology Research
Center, NRITLD, Shahid Beheshti University of Medical
Sciences, Tehran, Iran ,
Majid Malekmohammad |
Tracheal Diseases Research
Center, National Research Institute of Tuberculosis and
Lung Disease (NRITLD), Shahid Beheshti University of
Medical Sciences, Tehran, Iran,
Seyyed Reza Seyyedi |
3 Lung Transplantation
Research Center, Department of Cardiology, National
Research Institute of Tuberculosis and Lung Diseases
(NRITLD), Shahid Beheshti University of Medical
Sciences, Tehran, Iran
Seyed Mohammadreza Hashemian |
1 Clinical Tuberculosis and Epidemiology Research
Center, NRITLD, Shahid Beheshti University of Medical
Sciences, Tehran, Iran ,
|
|
| نشانی اینترنتی |
https://www.tanaffosjournal.ir/article_239972_b22b00e2634b4ecaa62a9166d9d7a817.pdf |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
|
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|